Claris Biotherapeutics is developing ocular biologic solution for the treatment of neurotrophic keratitis. The company is headquartered in Jersey City, New Jersey, the US. For a complete picture of ...
The first medical cure of a corneal infection due to an Acanthamoeba species is reported. The 44-year-old patient developed a suppurative keratitis associated with an epithelial defect, hypopyon, and ...
1 Department of Infectious and Tropical Diseases, Clinical Research Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK Background: A multicentre study was carried ...
The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.
1 Department of Ophthalmology, The China-Japan Union Hospital of Jilin University, Changchun, Jilin, China 2 Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin, ...
To compare safety, efficacy and cost–effectiveness of voriconazole with natamycin, a double-blinded RCT was conducted in two hospitals in India in 2010. The design was superior to antecedent ...